Multiple Myeloma
Multiple Myeloma is a hematologic cancer affecting plasma cells in the bone marrow, causing impaired immunity and bone destruction.
Symptoms include bone pain, anemia, frequent infections, and kidney dysfunction. Early diagnosis through blood tests, bone marrow biopsy, and imaging allows timely treatment with chemotherapy, targeted therapy, or stem cell transplant to improve survival and quality of life.
Causes and Risk Factors of Multiple Myeloma
Multiple Myeloma develops due to malignant transformation of plasma cells.
- Genetic mutations: Alterations in plasma cell DNA drive uncontrolled growth.
- Age: Commonly diagnosed after 60 years
- Family history of hematologic malignancies
Symptoms and Clinical Features
Symptoms may include:
- Bone pain, especially in the back or ribs
- Fatigue and anemia: Due to impaired blood cell production
- Frequent infections and kidney problems
- Hypercalcemia causing nausea, constipation, and confusion
Treatment Options for Multiple Myeloma
Treatment is tailored based on patient age, stage, and overall health.
- Chemotherapy: To control plasma cell proliferation
- Targeted therapy with proteasome inhibitors and immunomodulatory drugs
- Stem cell transplant: Autologous transplant to restore healthy marrow
- Radiotherapy for localized bone lesions
Why Choose Us for Multiple Myeloma
CureU Healthcare offers expert hematology and oncology care, stem cell transplant facilities, and personalized therapy plans for optimal outcomes.
Conclusion
Multiple Myeloma is manageable with early diagnosis and advanced treatment. CureU Healthcare provides comprehensive care from chemotherapy to transplant and follow-up.
